Skip to main content

Mobility Limitation

1
Pipeline Programs
5
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Astellas
AstellasChina - Shenyang
2 programs
1
reldesemtivPhase 1
Resistance TrainingN/A1 trial
Active Trials
NCT03083275Completed70Est. Feb 2017
March Biosciences
March BiosciencesTX - Houston
2 programs
TIME at HomeN/A1 trial
TIME™ at HomeN/A1 trial
Active Trials
NCT06245135Recruiting200Est. Mar 2026
NCT05369741Completed20Est. Jul 2022
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Lightweight wheelchairN/A1 trial
Active Trials
NCT01275313Completed258Est. Jun 2015
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Lofstrand CrutchesN/A1 trial
Active Trials
NCT04074252Withdrawn0Est. Jul 2022
Cytokinetics
CytokineticsSOUTH SAN FRANCISCO, CA
1 program
reldesemtivPHASE_11 trial
Active Trials
NCT03065959Terminated42Est. Oct 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Cytokineticsreldesemtiv
March BiosciencesTIME at Home
March BiosciencesTIME™ at Home
Angeles TherapeuticsLofstrand Crutches
AstellasResistance Training
Human BioSciencesLightweight wheelchair

Clinical Trials (6)

Total enrollment: 590 patients across 6 trials

NCT03065959Cytokineticsreldesemtiv

A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility

Start: Jun 2017Est. completion: Oct 201842 patients
Phase 1Terminated
NCT06245135March BiosciencesTIME at Home

TIME™ at Home Randomized Controlled Trial

Start: Jul 2024Est. completion: Mar 2026200 patients
N/ARecruiting
NCT05369741March BiosciencesTIME™ at Home

TIME™ at Home Feasibility Study: Evaluation of a Virtually Delivered, Community-based, Task-oriented Exercise Program

Start: Jan 2022Est. completion: Jul 202220 patients
N/ACompleted
NCT04074252Angeles TherapeuticsLofstrand Crutches

Mobility Impairment in the Northern Region of Malawi

Start: May 2019Est. completion: Jul 20220
N/AWithdrawn
NCT03083275AstellasResistance Training

Resistance Training in Older Adults With Limitations in Mobility

Start: Jan 2016Est. completion: Feb 201770 patients
N/ACompleted
NCT01275313Human BioSciencesLightweight wheelchair

Wheeled Mobility for Preventing Pressure Ulcers

Start: Apr 2011Est. completion: Jun 2015258 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 590 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.